Literature DB >> 25401469

Human glial chimeric mice reveal astrocytic dependence of JC virus infection.

Yoichi Kondo, Martha S Windrem, Lisa Zou, Devin Chandler-Militello, Steven J Schanz, Romane M Auvergne, Sarah J Betstadt, Amy R Harrington, Mahlon Johnson, Alexander Kazarov, Leonid Gorelik, Steven A Goldman.   

Abstract

Progressive multifocal leukoencephalopathy (PML) is a demyelinating disease triggered by infection with the human gliotropic JC virus (JCV). Due to the human-selective nature of the virus, there are no animal models available to investigate JCV pathogenesis. To address this issue, we developed mice with humanized white matter by engrafting human glial progenitor cells (GPCs) into neonatal immunodeficient and myelin-deficient mice. Intracerebral delivery of JCV resulted in infection and subsequent demyelination of these chimeric mice. Human GPCs and astrocytes were infected more readily than oligodendrocytes, and viral replication was noted primarily in human astrocytes and GPCs rather than oligodendrocytes, which instead expressed early viral T antigens and exhibited apoptotic death. Engraftment of human GPCs in normally myelinated and immunodeficient mice resulted in humanized white matter that was chimeric for human astrocytes and GPCs. JCV effectively propagated in these mice, which indicates that astroglial infection is sufficient for JCV spread. Sequencing revealed progressive mutation of the JCV capsid protein VP1 after infection, suggesting that PML may evolve with active infection. These results indicate that the principal CNS targets for JCV infection are astrocytes and GPCs and that infection is associated with progressive mutation, while demyelination is a secondary occurrence, following T antigen-triggered oligodendroglial apoptosis. More broadly, this study provides a model by which to further assess the biology and treatment of human-specific gliotropic viruses.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25401469      PMCID: PMC4348956          DOI: 10.1172/JCI76629

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  57 in total

1.  Astrocyte-mediated potentiation of inhibitory synaptic transmission.

Authors:  J Kang; L Jiang; S A Goldman; M Nedergaard
Journal:  Nat Neurosci       Date:  1998-12       Impact factor: 24.884

Review 2.  Progressive multifocal leukoencephalopathy.

Authors:  Joseph R Berger
Journal:  Curr Neurol Neurosci Rep       Date:  2007-11       Impact factor: 5.081

3.  Progressive multifocal leukoencephalopathy (PML) development is associated with mutations in JC virus capsid protein VP1 that change its receptor specificity.

Authors:  Leonid Gorelik; Carl Reid; Manuela Testa; Margot Brickelmaier; Simona Bossolasco; Annamaria Pazzi; Arabella Bestetti; Paul Carmillo; Ewa Wilson; Michele McAuliffe; Christopher Tonkin; John P Carulli; Alexey Lugovskoy; Adriano Lazzarin; Shamil Sunyaev; Kenneth Simon; Paola Cinque
Journal:  J Infect Dis       Date:  2011-07-01       Impact factor: 5.226

4.  Large T antigen promotes JC virus replication in G2-arrested cells by inducing ATM- and ATR-mediated G2 checkpoint signaling.

Authors:  Yasuko Orba; Tadaki Suzuki; Yoshinori Makino; Kanako Kubota; Shinya Tanaka; Takashi Kimura; Hirofumi Sawa
Journal:  J Biol Chem       Date:  2009-11-10       Impact factor: 5.157

Review 5.  Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research.

Authors:  Carol Kilkenny; William J Browne; Innes C Cuthill; Michael Emerson; Douglas G Altman
Journal:  PLoS Biol       Date:  2010-06-29       Impact factor: 8.029

Review 6.  Progressive multifocal leukoencephalopathy in patients on immunomodulatory therapies.

Authors:  Eugene O Major
Journal:  Annu Rev Med       Date:  2010       Impact factor: 13.739

7.  Neonatal chimerization with human glial progenitor cells can both remyelinate and rescue the otherwise lethally hypomyelinated shiverer mouse.

Authors:  Martha S Windrem; Steven J Schanz; Min Guo; Guo-Feng Tian; Vaughn Washco; Nancy Stanwood; Matthew Rasband; Neeta S Roy; Maiken Nedergaard; Leif A Havton; Su Wang; Steven A Goldman
Journal:  Cell Stem Cell       Date:  2008-06-05       Impact factor: 24.633

8.  An siRNA against JC virus (JCV) agnoprotein inhibits JCV infection in JCV-producing cells inoculated in nude mice.

Authors:  Tomoko Matoba; Yasuko Orba; Tadaki Suzuki; Yoshinori Makino; Hideo Shichinohe; Satoshi Kuroda; Takahiro Ochiya; Hiroshi Itoh; Shinya Tanaka; Kazuo Nagashima; Hirofumi Sawa
Journal:  Neuropathology       Date:  2007-12-21       Impact factor: 1.906

9.  Sequencing and analysis of JC virus DNA from natalizumab-treated PML patients.

Authors:  Carl E Reid; Huo Li; Gargi Sur; Paul Carmillo; Steven Bushnell; Rich Tizard; Michele McAuliffe; Christopher Tonkin; Kenneth Simon; Susan Goelz; Paola Cinque; Leonid Gorelik; John P Carulli
Journal:  J Infect Dis       Date:  2011-07-15       Impact factor: 5.226

10.  Adaptive mutations in the JC virus protein capsid are associated with progressive multifocal leukoencephalopathy (PML).

Authors:  Shamil R Sunyaev; Alexey Lugovskoy; Kenneth Simon; Leonid Gorelik
Journal:  PLoS Genet       Date:  2009-02-06       Impact factor: 5.917

View more
  37 in total

1.  Synthetic antibodies and peptides recognizing progressive multifocal leukoencephalopathy-specific point mutations in polyomavirus JC capsid viral protein 1.

Authors:  Gang Chen; Leonid Gorelik; Kenneth J Simon; Alevtina Pavlenco; Anne Cheung; Margot Brickelmaier; Ling Ling Chen; Ping Jin; Paul H Weinreb; Sachdev S Sidhu
Journal:  MAbs       Date:  2015-04-16       Impact factor: 5.857

Review 2.  Animal Models for Progressive Multifocal Leukoencephalopathy.

Authors:  Martyn K White; Jennifer Gordon; Joseph R Berger; Kamel Khalili
Journal:  J Cell Physiol       Date:  2015-12       Impact factor: 6.384

Review 3.  Persistence and pathogenesis of the neurotropic polyomavirus JC.

Authors:  Hassen S Wollebo; Martyn K White; Jennifer Gordon; Joseph R Berger; Kamel Khalili
Journal:  Ann Neurol       Date:  2015-03-06       Impact factor: 10.422

4.  The Greater Affinity of JC Polyomavirus Capsid for α2,6-Linked Lactoseries Tetrasaccharide c than for Other Sialylated Glycans Is a Major Determinant of Infectivity.

Authors:  Luisa J Ströh; Melissa S Maginnis; Bärbel S Blaum; Christian D S Nelson; Ursula Neu; Gretchen V Gee; Bethany A O'Hara; Nasim Motamedi; Daniel DiMaio; Walter J Atwood; Thilo Stehle
Journal:  J Virol       Date:  2015-04-08       Impact factor: 5.103

5.  An animal model for progressive multifocal leukoencephalopathy.

Authors:  Sheila A Haley; Walter J Atwood
Journal:  J Clin Invest       Date:  2014-11-17       Impact factor: 14.808

6.  Susceptibility of Primary Human Choroid Plexus Epithelial Cells and Meningeal Cells to Infection by JC Virus.

Authors:  Bethany A O'Hara; Gretchen V Gee; Walter J Atwood; Sheila A Haley
Journal:  J Virol       Date:  2018-03-28       Impact factor: 5.103

7.  microRNA-219 Reduces Viral Load and Pathologic Changes in Theiler's Virus-Induced Demyelinating Disease.

Authors:  Ana Lis Moyano; Jeffrey Steplowski; Haibo Wang; Kyung-No Son; Diana I Rapolti; Jeffrey Marshall; Vince Elackattu; Michael S Marshall; Amy K Hebert; Cory R Reiter; Viviana Ulloa; Katarzyna C Pituch; Maria I Givogri; Q Richard Lu; Howard L Lipton; Ernesto R Bongarzone
Journal:  Mol Ther       Date:  2018-01-17       Impact factor: 11.454

8.  Humanized neuronal chimeric mouse brain generated by neonatally engrafted human iPSC-derived primitive neural progenitor cells.

Authors:  Chen Chen; Woo-Yang Kim; Peng Jiang
Journal:  JCI Insight       Date:  2016-11-17

Review 9.  How to make an oligodendrocyte.

Authors:  Steven A Goldman; Nicholas J Kuypers
Journal:  Development       Date:  2015-12-01       Impact factor: 6.868

10.  JC Polyomavirus Entry by Clathrin-Mediated Endocytosis Is Driven by β-Arrestin.

Authors:  Colleen L Mayberry; Ashley N Soucy; Conner R Lajoie; Jeanne K DuShane; Melissa S Maginnis
Journal:  J Virol       Date:  2019-04-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.